1. Chinese
  2. English
Language entrance:
News
Hot News:
  1. 1ZO Skin Health unveils new phys
  2. 2Simple-to-Use Polypropylene Pre
  3. 3Some Unusual API and CAS Number
  4. 4Cipla unveils Pirfenidone for I
  5. 5Inovio Reports Unprecedented T-
  6. 6Immunomedics shows decline in Q
Contact US

    Shanghai Xianjie Chemtech Co.,Ltd.
        Tel:   8621- 5793·2466 
        Fax:   8621- 6192·7З11
        Web:  www.xjchem.net
        Email:  Sales#xjchem.net

Technical Articles
  • ZO Skin Health unveils new physician skincare line2012-03-19

    ZO Skin Health unveils new physician skincare line ZO Skin Health has introduced a new medical skincare line, ZO Medical, to address a therapeutic, maintenance, daily skin care, and protection applications. ZO Medical utilizes the most pote…

  • Simple-to-Use Polypropylene Pre-Filled Syringes2011-09-17

    Simple-to-Use Polypropylene Pre-Filled Syringes Generic medicines supplier Aguettant, a subsidiary of Laboratoire Aguettant Pharma Company based in Lyon, has designed low-cost yet safe polypropylene (PP) pre-filled syringes with stopper ste…

  • Some Unusual API and CAS Number2010-12-21

    Some Unusual API and CAS Number CAS No. Aztreonam 78110-38-0 5-Fluorouracil 51-21-8 Acyclovir 59277-89-3 Alprazolam 28981-97-7 Amikacin Sulfate 39831-55-5 Amprolium HCL 137-88-2 Anastrozole 120511-73-1 Aniracetam 72432-10-1 Artimether 71963…

  • Cipla unveils Pirfenidone for IPF patients in India2010-10-22

    Cipla unveils Pirfenidone for IPF patients in India Cipla has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. Pirfenidone is a novel anti-fibrotic drug which through clinical trials has shown to slow…

  • Inovio Reports Unprecedented T-Cell Response from Cervical Ca2010-09-14

    Inovio Reports Unprecedented T-Cell Response from Cervical Cancer Vaccine Inovio Pharmaceuticals has announced strong results from a Phase I dose-escalation study of VGX-3100, a DNA vaccine to treat pre-cancerous cervical dysplasias and cer…

  • Immunomedics shows decline in Q2 revenues2010-08-30

    Immunomedics shows decline in Q2 revenues Immunomedics has posted a net income of $744,547 for the second quarter 2010, or $0.01 per diluted share, compared to net income of $854,695, or $0.01 per diluted share, for the comparable period in…

  • Methods for the preparation, isolation and purification of ep2010-08-27

    The present invention relates to improved methods for the production, isolation and purification of epothilone B. These methods include, for example, a fermentation process for the production of epothilone B, isolation via adsorption onto a resin, and…

  • Synthetic Routes of Patupilone, (-)-Epothilone B, Epothilone2010-08-15

    Synthetic Routes of Patupilone, (-)-Epothilone B, Epothilone B, EPO-906,152044-5 【Name】Patupilone, (-)-Epothilone B, Epothilone B, EPO-906 【Chemical】 (4S,7R,8S,9S,13R,14S,16S)-13,14-Epoxy-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[1-m…

firstPage 1 [2] [3] nextPage lastPage
Copyright 2004-2009 上海献捷化工科技有限公司 版权所有 友情链接:分散剂 | sitemap